Mycobutin 150 Mg Capsules 150 mg Capsules
PDF Leaflet Revision Date: 24 April 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment and prophylaxis of tuberculosis and atypical mycobacterial infections.
Dosage (summary)
1 capsule (150 mg) daily for pulmonary TB; 2-3 capsules daily for multidrug-resistant TB; 3-4 capsules daily for MAC infections.
Special Populations
- Severe hepatic impairment
- Severe renal impairment
- Elderly
Pregnancy & Breastfeeding
Safety in pregnancy and lactation not established.
Key Drug Interactions
- Clarithromycin
- Protease inhibitors
- Antiretrovirals
Contraindications
- Hypersensitivity to rifabutin
- HIV patients on clarithromycin
Common side effects
- Leukopenia
- Nausea
- Increased hepatic enzymes
- Rash
Counselling Points
- Monitor for skin reactions.
- Urine may turn red-orange.
- Use alternative contraception methods.
Serious warnings
- Risk of uveitis
- Clostridium difficile-associated diarrhea
- Severe cutaneous adverse reactions
Important Disclaimer
The Mycobutin 150 Mg Capsules 150 mg Capsules professional information leaflet below is the property of Pfizer Laboratories and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
